ICTQual AB Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics)
The ICTQual AB Level 7 Postgraduate Diploma in Pharmacoeconomics is a specialised programme designed for professionals seeking to advance their expertise at the intersection of healthcare, economics, and pharmaceutical sciences. This qualification equips learners with the knowledge and analytical skills required to evaluate the cost-effectiveness of healthcare interventions, inform policy decisions, and optimise resource allocation within national and international health systems.
Pharmacoeconomics has become an essential discipline in today’s global healthcare landscape, where the demand for effective yet affordable therapies continues to grow. This diploma prepares learners to critically assess economic models, apply advanced methodologies in health economics, and interpret outcomes that guide evidence-based decisions. By integrating scientific, financial, and policy-driven perspectives, the programme offers a strong foundation for shaping the future of pharmaceutical and healthcare strategies.
The course is particularly valuable for professionals who aspire to enhance their career prospects, expand their knowledge base, and strengthen their Continuing Professional Development (CPD). It provides opportunities to deepen understanding of drug evaluation, healthcare financing, and policy implementation while developing transferable skills in research, data analysis, and leadership.
With its focus on practical application and professional growth, the Level 7 Postgraduate Diploma in Pharmacoeconomics supports learners in achieving progression to advanced academic study, senior professional roles, or consultancy opportunities. Whether working within the pharmaceutical industry, public health organisations, or academic institutions, graduates of this programme are well positioned to contribute to sustainable healthcare solutions and global health outcomes.
Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics)
To enrol in ICTQual AB Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics)), learner must meet the following entry requirements:
This qualification, the ICTQual AB Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics), consists of 6 mandatory units.
- Principles of Pharmacoeconomics and Health Economics
- Pharmaceutical Policy and Healthcare Systems
- Economic Evaluation of Medicines and Health Technologies
- Biostatistics and Data Analysis in Pharmacoeconomics
- Research Methods in Health Economics and Outcomes Research
- Innovation, Ethics, and Leadership in Pharmacoeconomics
Learning Outcomes for the Study Units:
Principles of Pharmacoeconomics and Health Economics
- Demonstrate a comprehensive understanding of the fundamental concepts of pharmacoeconomics and health economics.
- Critically analyse the economic principles underlying healthcare resource allocation and decision-making.
- Evaluate the role of pharmacoeconomics in assessing healthcare interventions at both national and international levels.
Pharmaceutical Policy and Healthcare Systems
- Understand the structure and functioning of healthcare systems worldwide and their relationship with pharmaceutical policy.
- Assess how healthcare financing models influence drug pricing, reimbursement, and accessibility.
- Critically examine the role of pharmacoeconomics in shaping evidence-based healthcare and pharmaceutical policy.
Economic Evaluation of Medicines and Health Technologies
- Apply advanced methods of economic evaluation, including cost-effectiveness, cost-utility, and cost-benefit analysis.
- Assess the economic impact of medicines, medical devices, and health technologies on healthcare systems.
- Interpret and communicate evaluation results to support healthcare decision-making and policy development.
Biostatistics and Data Analysis in Pharmacoeconomics
- Develop advanced skills in biostatistical techniques relevant to health economics research.
- Use statistical software and data analysis tools to interpret healthcare and pharmaceutical datasets.
- Critically evaluate the reliability, validity, and limitations of statistical data in pharmacoeconomic research.
Research Methods in Health Economics and Outcomes Research
- Design and conduct independent research projects in pharmacoeconomics and health outcomes.
- Apply qualitative and quantitative research methodologies to investigate healthcare and pharmaceutical issues.
- Analyse and present research findings in line with academic and professional standards.
Innovation, Ethics, and Leadership in Pharmacoeconomics
- Demonstrate leadership skills in managing pharmacoeconomic projects within healthcare and pharmaceutical contexts.
- Evaluate the ethical implications of economic decisions in healthcare resource allocation.
- Promote innovation and strategic leadership to address global healthcare and pharmaceutical challenges.
The ICTQual AB Level 7 Postgraduate Diploma in Pharmacoeconomics provides learners with advanced knowledge and highly transferable skills that can significantly enhance career prospects, academic opportunities, and professional recognition. Pharmacoeconomics has become an essential field in the global healthcare environment, where governments, pharmaceutical companies, and health organisations seek cost-effective strategies to improve access to medicines and therapies. It also supports Continuing Professional Development (CPD), ensuring that learners remain competitive, adaptable, and equipped to contribute to healthcare decision-making at an international scale.
Academic Progression
- Direct progression in fields such as health policy, pharmaceutical economics, global healthcare management, and outcomes research.
- Specialisation through targeted postgraduate certifications in areas such as global drug policy, advanced biostatistics, health technology assessment (HTA), or pharmaceutical market access.
- Opportunities to publish academic research, contribute to scientific journals, and present at international conferences to strengthen professional standing.
Professional Career Pathways
- Senior positions in pharmaceutical companies, working in roles such as market access managers, pharmacoeconomic analysts, and health outcomes researchers.
- Career advancement in public health institutions and government agencies responsible for healthcare financing, reimbursement, and pricing strategies.
- Employment in international organisations such as World Health Organisation (WHO), public health NGOs, or regional healthcare authorities as policy specialists.
- Senior roles within healthcare consultancy firms, contract research organisations, and biopharmaceutical companies.
- Positions in clinical research, with a focus on evaluating economic and therapeutic outcomes of new medicines and health technologies.
Industry and Consultancy Opportunities
- Consultancy roles advising on healthcare policy, drug pricing, and reimbursement strategies across global markets.
- Independent expert roles supporting pharmaceutical companies, insurance organisations, and healthcare ministries in evaluating cost-effectiveness of medicines.
- Advisory positions within global healthcare initiatives, providing technical input on economic evaluations and health technology assessments.
- Opportunities to collaborate with academic institutions, think tanks, and international policy groups shaping sustainable healthcare systems.
- Engagement in global projects that address economic challenges in healthcare delivery, including access to innovative treatments in low- and middle-income countries.
Continuing Professional Development (CPD)
- Participation in international workshops, CPD courses, and professional training to remain updated with current methodologies in pharmacoeconomics.
- Active involvement in global professional associations such as health economics and outcomes research networks.
- Development of lifelong learning skills, enabling continuous advancement in leadership, innovation, and applied research.
- Recognition as a skilled professional capable of influencing healthcare policies, driving pharmaceutical strategies, and supporting sustainable health systems worldwide.
- Strengthened ability to build international networks and collaborations with healthcare leaders, researchers, and policymakers.
